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Abstract
Background: Globally, staphylococci have developed resistance to many antibiotics. New approaches to chemotherapy
are needed and one such approach could be to use plant derived actives with conventional antibiotics in a synergestic
way. The purpose of this study was to isolate α-mangostin from the mangosteen (Garcinia mangostana L.; GML) and
investigate antibacterial activity and mechanisms of action when used singly and when combined with oxacillin against
oxacillin-resistant Staphylococcus saprophyticus (ORSS) strains. The isolated α-mangostin was confirmed by HPLC
chromatogram and NMR spectroscopy. The minimum inhibitory concentration (MIC), checkerboard and killing
curve were determined. The modes of action of these compounds were also investigated by enzyme assay,
transmission electron microscopy (TEM), confocal microscopic images, and cytoplasmic membrane (CM)
permeabilization studies.
Results: The MICs of isolated α-mangostin and oxacillin against these strains were 8 and 128 μg/ml, respectively.
Checkerboard assays showed the synergistic activity of isolated α-mangostin (2 μg/ml) plus oxacillin (16 μg/ml) at a
fractional inhibitory concentration index (FICI) of 0.37. The kill curve assay confirmed that the viability of oxacillin-resistant
Staphylococcus saprophyticus DMST 27055 (ORSS-27055) was dramatically reduced after exposure to isolated α-mangostin
(2 μg/ml) plus oxacillin (16 μg/ml). Enzyme assays demonstrated that isolated α-mangostin had an inhibitory activity
against β-lactamase in a dose-dependent manner. TEM results clearly showed that these ORSS-27055 cells treated with
this combination caused peptidoglycan and cytoplasmic membrane damage, irregular cell shapes and average cell areas
were significantly larger than the control. Clearly, confocal microscopic images confirmed that this combination caused
considerable peptidoglycan damage and DNA leakage. In addition, the CM permeability of ORSS-27055 was also
increased by this combination of actives.
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Conclusions: These findings provide evidence that isolated α-mangostin alone has not only some activity but
also shows the synergistic activity with oxacillin against ORSS-27055. The chromone and isoprenyl structures
could play a significant role in its action. This synergistic activity may involve three mechanisms of action. Firstly,
potential effects of cytoplasmic membrane disruption and increases permeability. Secondly, inhibit β-lactamase
activity. Finally, also damage to the peptidoglycan structure. We proposes the potential to develop a novel
adjunct phytopharmaceutical to oxacillin for the treatment of ORSS. Future studies require clinical trials to
establish if the synergy reported can be translated to animals and humans.
Keywords: α-mangostin, Garcinia mangostana, Oxacillin, Oxacillin-resistant S. saprophyticus, Synergistic activity,
Mechanism of action
Abbreviations: CAMHB, Cation-adjusted Meuller-Hinton broth; CM, Cytoplasmic membrane; FIC, Fraction
inhibitory concentration; FICI, Fraction inhibitory concentration index; GML, Garcinia mangostana L.;
MHA, Meuller-Hinton agar; MHB, Meuller-Hinton broth; MIC, Minimum inhibitory concentration; ONPG,
O-nitrophenol-β-D-galactoside; ORSS, Oxacillin-resistant Staphylococcus saprophyticus; ORSS-20755, Oxacillin-
resistant Staphylococcus saprophyticus DMST 20755; TEM, Transmission electron microscopy.
Background
Antibiotic resistance in staphylococci has been globally
documented [1]. The resistance of these strains to
board spectraum β-lactam antibiotics, such as methicil-
lin, oxacillin, and flucloxacillin, have emerged rapidly
only a few years after the introduction of the first drug
in this class and there has been a steady risen in the in-
cidence of methicillin-resistant S. aureus (MRSA) in
clinical isolates [1, 2]. A previous study of 12 hospitals
in Virginia, USA found that overall 53 % of S. aureus
isolates were resistant to oxacillin [3]. In addition, to
pathogenic S. aureus, currently S. saprophyticus, a co-
agulase- negative staphylococcus that frequently causes
community-associated uncomplicated urinary tract in-
fection (UTI) in young and middle-aged women, has
become resistant to β-lactam antibiotics, such as methi-
cillin by acquisition of staphylococcal cassette chromo-
some mec (SCCmec) element [4, 5]. These problems
present an urgent need to search for new antibiotics
and novel approaches to treating these bacterial infec-
tions. Plant-derived antimicrobials are a potential
source of novel therapeutics because plants are known
to produce various antimicrobial molecules to protect
themselves from plant or environmental pathogens [6].
Furthermore, drug combination strategies, in particular,
phytochemical and antibiotic combination approachs
have been recommended in several studies to combat
multiple drug-resistant bacteria [7–9]. Mangosteen (the
queen of fruit), belonging to the family Guttiferae, is a
tropical evergreen tree that is widely cultivated
throughout India, Myanmar, Malaysia, Philippines, Sri
Lanka, and Thailand [10]. The pericarp (peel, rind, and
hull) or the ripe fruit of GML has been traditionally
used for the treatment of diarrhea, inflammation, ab-
dominal pain, dysentery, wound infection, suppuration
and chronic ulcers [11]. The α-mangostin, a xanthone
derivative, has been found to possess several beneficial
biological activities, such as a competitive antagonist of the
histamine H1 receptor and weak antioxidant properties
[12], antibacterial activity against Helicobacter pylori, anti-
inflammatory activities, inhibition of oxidative damage by
human low-density lipoproteins (LDL), antimicrobial activ-
ity against methicillin-resistant Staphylococcus aureus [13].
However, the recent studies have not reported on the anti-
bacterial activity of α-mangostin and synergism with oxacil-
lin against oxacillin-resistant S. saprophyticus. To this end,
the present study was instigated to elucidate antibacterial
and synergistic activity of α-mangostin isolated from the
GML pericarp and oxacillin either alone or in combination
against this strain. The antibacterial actions and cell line
toxicity of these compounds were also investigated.
Methods
Plant materials, β-lactam antibiotics, bacterial strains, and
cell line
The dried fruit hulls of mangosteen were purchased locally
in Nakhon-Ratchasima, Thailand. The samples were
identified by Dr. Paul J. Grote, Suraneree University of
Technology. The voucher specimens (SGM0804U)
were deposited in the School of Pharmacology, Institute
of Science, Suranaree University of Technology,
Nakhon-Ratchasima, Thailand. The mature fruit was
cleaned. The fruit rinds were cut into small pieces,
dried in a hot oven at 50 °C for 72 h and ground into
powder, passed through a sieve (20 mesh). The pow-
dered sample was kept in an airtight container pro-
tected from light until used.
All clinical isolates of S. saprophyticus were obtained
from the Department of Medical Science, National Institute
of Health, Ministry of Public Health, Bangkok, Thailand.
The susceptible strain S. aureus ATCC 29213, a reference
strain, was obtained from the American Type Culture
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Collection (ATCC). Oxacillin, Nisin, o-nitrophenol-β-
D-galactoside (ONPG), α-mangostin standard, and β-
lactamase type IV isolated from E. cloacae were
obtained from Sigma-Aldrich, UK. Meuller-Hinton
broth (MHB) and Mueller-Hinton agar (MHA) were
purchased from Oxoid (Basingstoke, UK).
The 3T3-L1 mouse embryonic fibroblasts and bovine calf
serum (CBS) were purchased from the American Type Cul-
ture Collection (ATCC, USA). 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT), Dulbecco’s Modi-
fied Eagle’s medium (DMEM), Fetal bovine serum (FBS),
Penicillin-Streptomycin, N-2-hydroxyethylpiperazine-N-2-
ethane sulfonic acid (HEPES) were obtained from Gibco
Invitrogen (Grand Island, NY, USA).
Isolation and purification of α-mangostin
α-mangostin from the pericarp of GML was isolated and
purified according to previous methods with some modi-
fications [12, 14]. Briefly, 1 kg of dried pericarp powder
of GML was extracted successively with n-hexane, di-
chloromethane (CH2Cl2), ethanol, and acetone using a
Soxhlet extractor. The filtered extracts were then con-
centrated using a rotatory evaporator to provide a
yellowish power for n-hexane (84 g) and dichlorometh-
ane (106 g), brown sticky semi-solid for ethanol (262 g)
and acetone (130 g) respectively.
The CH2Cl2 crude extract was further separated by silica
gel column chromatography to yield 11 fractions. These
fractions were subjected to HPLC (C18 column, a mo-
bile phase of methanol-water (85:15) and a flow rate of
1.0 ml/min, a photodiode array detector) and purified
using preparative thin layer chromatography to obtain
isolated α-mangostin. The α-mangostin was analyzed
by HPLC and its chemical structure was elucidated by
1H NMR and 13C NMR. The spectrum structure data
of this compound was compared with those previously
reported [15].
Standardised bacterial suspensions
To select bacterial suspensions with a known viable
count, the method of Liu et al. [16] was followed with
little modifications. MHA and Cation-adjusted Mueller-
Hinton broth (CAMHB) were used as a medium.
Minimum inhibitory concentration (MIC) and
checkerboard determinations
The antibacterial activity and drug interaction of isolated
α-mangostin from the pericarp of GML with oxacillin
were performed by MIC and checkerboard assays, re-
spectively using broth macrodilution procedure. These
assays were conducted following the methods of Clinical
and Laboratory Standard Institute guidelines [16, 17]. In
summary, 0.25 ml of 5 × 106 cfu/ml bacterial suspensions
was added to a series of 2.25 ml CAMHB plus 1 in 10
serial dilutions of the α-mangostin plus oxacillin combi-
nations to give 5x105 cfu/ml. Tubes of the broth without
antimicrobialsl were used as the control. The cultures
were incubated for 24 h at 37 °C. The tests were carried
out in triplicate. MICs were determined for each anti-
bacterial combination and the isobolograms were plot-
ted. The interaction between the two agents was
calculated by the fractional inhibitory concentration
(FIC) index of the combination. The FIC of each agent
was calculated by the complete growth inhibition of
microorganism in the combination tube. The following
formula was used for FIC index calculation: FIC of α-
mangostin =MIC α-mangostin in the combination/MIC
of α-mangostin alone; FIC of oxacillin =MIC of oxacillin
in the combination/MIC of oxacillin alone; therefore,
FIC index = FIC of α-mangostin + FIC of oxacillin. When
the FIC index of the combination is equal to or less than
0.5, the combination is defined as synergistic; when the
FIC index falls between 0.5 and 4.0, it indicates ‘no inter-
action’ between the agents and a value above four is
considered to show antagonism between the two com-
pounds [18]. S. aureus ATCC 29213 was used as positive
control. The MICs and FIC index is presented as the
median values obtained in duplicates from three inde-
pendent experiments.
Kill curve determinations (Viable counts)
The experiment was carried out to confirm antibacterial
and synergistic activities of isolated α-mangostin from
the pericarp of GML when used singly and in combin-
ation with oxacillin as previously described by Mun
et al. and Richards et al. [19, 20]. Compounds were used
at the half minimal inhibitory concentration (1/2-MICs)
when each compound was assessed alone. However, to
study the effect of the compounds in combination, each
compound was used at the MIC that yielded synergism.
Enzyme assays
The ability of isolated α-mangostin from the pericarp of
GML to inhibit the activity of β-lactamase type IV isolated
from E. cloacae was determined in accordance with the
methods of Eumkeb et al. and Richards et al. [21, 22]. Con-
cisely, benzylpenicillin, a substrate for β-lactamase type IV,
was adjusted to concentrations sufficient to hydrolyze 50-
60 % substrate within 5 min, β-lactamase at 100 μg/ml was
used. The α-mangostin at 1, 2, 4 and 8 μg/ml were preincu-
bated with the enzyme in 50 mM sodium phosphate buffer
(pH 7.0) at 37 °C for 5 min before adding a substrate. A
time - course assay was performed at 0, 5, 10, 15 and
20 min using methanol/acetic acid (100:1) as a stopping
agent. Aliquots (10 μl) of each sample were injected onto a
reverse-phase HPLC (Ascentis C18 column) to analyse the
remaining benzylpenicillin. The mobile phase consisted of
10 mM ammonium acetate (pH 4.5 acetic acid): acetonitrile
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(75:25) with a flow rate of 1 ml/min, UV detection of peaks
was at 200 nm,, and the column maintained at 35 °C. The
quantity of remaining benzylpenicillin was calculated by
comparing the area under the chromatographic curve.
Transmission electron microscopy (TEM)
To determine the ultrastructure morphology of bacteria
after treatment with isolated α-mangostin from the peri-
carp of GML either alone or in combination with oxacil-
lin, the method of Richards et al. [22] was followed. To
investigate the mechanism of action of these agents, the
half-MICs of both compounds used alone and Sub-FICs
of the combination, were chosen for examination. To
confirm the effects of these agents either used singly and
in combination on cell size, the cell area from micro-
graphs were analyzed by measuring cell width multiplied
by cell length (nm2). The experiment was performed in
triplicate, and the cell areas are displayed as mean ±
SEM [23].
Immunofluorescence staining and confocal microscopy
The disruption of peptidoglycan after exposure to α-
mangostin either used singly or in conjunction with oxa-
cillin was performed using immunofluorescence and vi-
sualized under a confocal laser scanning microscope
following the method of Teethaisong et al. [24]. Shortly,
after the FIC index was obtained from checkerboard, the
half-MICs value of isolated α-mangostin or oxacillin
alone and the 3/4 FIC of this combination that showed
synergistic FIC index was chosen for examination. The
cells grown without any antibacterial agent were
employed as control [25].
Cytoplasmic membrane (CM) permeabilization assays
Two methods were used to assess CM permeabilization.
Firstly; the CM permeabilization experiment was per-
formed, with some modifications, to confirm results as pre-
viously described by Shen et al. and Zhou et al. [26, 27].
Shortly after the FIC index was determined by the checker-
board assay, the half-MIC values for isolated α-mangostin
or oxacillin alone, and the 3/4 MIC values for this combin-
ation that indicated synergistic FIC index were selected
against ORSS to measure CM permeability. This method
was performed by measuring the release of UV-absorbing
material (Varian’s Cary 100 UV-Vis spectrophotometer,
Varian, Inc., California, USA) [21].
Secondly, the α-mangostin-induced permeabilization of
the CM of ORSS was determined essentially as recently de-
scribed [28]. In brief, to assay CM permeabilization, the
wells contained 50 μl ONPG plus either half-MIC values
for isolated α-mangostin or oxacillin alone and the 3/4
MIC values for this combination that indicated synergistic
FIC index were prepared shortly before the experiment.
Finally, 50 μl of cell suspension (OD 0.3) was added to the
Table 1 The 300 MHz 1H NMR (acetone-d6) spectral data of
α-mangostin
Chemical Shift (δ, ppm) Assignment Chemical Shift (δ, ppm)
from reference [15]
13.78 singlet, OH-1 13.72
6.82 singlet, H-5 6.72
6.40 singlet, H-4 6.25
5.27 triplet, H-12, H-17 5.26
4.13 doublet, H-11 4.10
3.80 singlet, 7-OMe 3.78
3.35 doublet, H-16 3.37
2.07 singlet, H-20 1.83
2.05 singlet, H-15 1.82
1.81 singlet, H-14 1.71
1.65 singlet, H-19 1.68
Table 2 The 300 MHz 13C NMR (acetone-d6), spectral data of
α-mangostin
Chemical Shift (δ, ppm) Assignment Chemical Shift (δ, ppm)
from reference [15]
182.81 C-9 181.8
162.92 C-3 161.6
161.40 C-1 160.2
157.39 C-6 155.4
156.23 C-10a 155.2
155.65 C-4a 154.8
144.51 C-7 142.7
138.14 C-8 137.2
131.39 C-13 131.7
124.82 C-17 123.4
123.50 C-12 122.1
112.06 C-8a 111.7
111.00 C-2 109.7
103.63 C-9a 103.1
102.67 C-5 101.6
93.15 C-4 92.4
61.31 7-OCH3 61.2
26.89 C-11 26.3
25.92 C-14 25.7
25.88 C-19 20.7
22.00 C-16 21.3
18.29 C-20 18.1
17.90 C-15 17.7
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wells to give a final concentration of 100 μg/ml ONPG.
After warming to 37 °C the plates were positioned in the
plate reader at 37 °C. ONPG uptake and cleavage by β-
galactosidase within the cytoplasm was characterized by
monitoring absorption over a period of 120 min at 420 nm.
Complete permeabilization was induced in the presence of
0.5 μg/ml Nisin as a positive control and wells lacking
drugs or isolated α-mangostin test served as a negative con-
trol [29, 30].
In vitro cytotoxicity test (MTT assays)
The 3T3-L1 preadipocytes were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) with high glucose,
supplemented with 10 % CBS, 1.5 mg/ml sodium bicar-
bonate, 100 U/ml penicillin and 100 μg/ml streptomycin
until confluent. The cells were maintained at 37 °C in
5 % CO2 and 95 % humidity. The cytotoxic effect of α-
mangostin, oxacillin, either alone or in combination on
cell proliferation was determined using a tetrazolium
dye (MTT) in a colorimetric assay [31]. Briefly, the cells
were seeded in a 96-well plate at a density of 5 × 103
cells/well. The cells were allowed to adhere for 48 h and
then were treated with various concentrations of three
compounds for 24 h. After incubation, the cultured
medium was removed, and 0.5 mg/ml of MTT was
added. Then, cells were further incubated for 4 h at 37 °C.
Formazan crystals formed by viable cells were dissolved in
DMSO and absorbance was measured at 540 nm with a
microplate spectrophotometer (Benchmark Plus, Bio-Rad,
Japan).
Statistical analysiss
The experiments were carried out in triplicate; data were
expressed as mean ± standard error of the mean (SEM).
Significant differences in the enzyme assay among each
of treated groups at the same time, the cell area of each
treated group, CM permeabilization, and MTT assays
were analysed by one-way ANOVA followed by Scheffe’s
posthoc test. The p < 0.01 was considered as the statisti-
cally significant difference.
Results and discussion
Isolation, purification and identification of α-mangostin
The isolated α-mangostin, the percent yield of α-
mangostin at 0.016 % (w/w) of dried powder, from the
pericarp of GML, was obtained and the chemical
structure of α-mangostin from 1H NMR and 13C NMR
(Tables 1 and 2) compared to the reference as illus-
trated in Fig. 1. Also, the results from HPLC chro-
matograms of this isolated α-mangostin exhibited a
major peak of isolated α-mangostin from the pericarp
of GML (Fig. 2a) which is practically the same as a
major peak of α-mangostin standard (Fig. 2b). The
purity (HPLC) of isolated α-mangostin was 98.0 %.
MIC and checkerboard determinations
The MIC results for isolated α-mangostin, dissolved in
1 % DMSO, from the pericarp of GML, oxacillin, and
nisin against all tested S. saprophyticus strains are pre-
sented in Table 3. The results indicated that the MICs
for isolated α-mangostin, oxacillin, and nisin against all
these strains were 8, 128, and 256 μg/ml, respectively.
These results indicated that these strains were resistant
to oxacillin. Although, the positive control, Staphylococ-
cus aureus ATCC 29213, was susceptible to oxacillin at
MIC 0.5 μg/ml [32]. The isolated α-mangostin exhibited
some inhibitory effect against these strains. These results
are in agreement with the studies of Chomnawang et al.
and Iinuma et al. who reported antibacterial activity of
bioactive compounds from the pericarp of GML extracts
against MRSA, Staphylococcus epidermidis and Propioni-
bacterium strains [13, 33]. Furthermore, previous find-
ings found that the Garcinia mangostana extract
exhibited MIC values of 0.039 mg/ml against both Propi-
onibacterium acnes and Staphylococcus epidermidis [34].
The FIC indices for isolated α-mangostin plus oxacillin
against all tested S. saprophyticus strains were 0.37.
These results indicated that these combinations demon-
strated synergistic activity against these strains [7, 18].
These findings suggest that isolated α-mangostin from
the pericarp of GML extract not only has some antibac-
terial activity of their own against these strains but also
have the ability to reverse the resistance of such bacterial
strains by synergy with oxacillin.
Kill curve assays
The results for the separate and combined effects of
isolated α-mangostin from the pericarp of GML and
oxacillin on viable counts of ORSS are presented in
Fig. 3. The control showed no reduction in the counts
of cfu from control inoculum. The viable counts for the
cells treated with isolated α-mangostin at 4 μg/ml were
rather lower than that of oxacillin at 64 μg/ml (between
1 and 24 h). Clearly, the combination of 2 μg/ml
Fig. 1 Structure of α-mangostin
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isolated α-mangostin and 16 μg/ml oxacillin greatly de-
creased the cell count to 1 × 103 cfu/ml after 4 h to
24 h. These results confirmed the checkerboard assay
results, which indicated synergistic activity that the
combination produced a decrease of ≥ 2 log10 cfu/ml,
compared with oxacillin treatment alone [35]. These
results are consistent with those of Eumkeb et al. that
galangin plus amoxicillin exhibited synergistic activity
against penicillin-resistant S. aureus strains at an FIC
index of 0.05 [9]. Apart from this, previous findings re-
ported that a synergistic effect using flavonoids and
oxacillin against vancomycin-intermediate S. aureus
Table 3 Minimum inhibitory concentration (MIC) of oxacillin, α-mangostin, and nisin alone and in combination
Strains MIC (μg/ml) FIC (μg/ml) FIC index
OXA AMT NIS OXA + AMT OXA + AMT
S. saprophyticus DMST 27055 128 R 8 256 16 + 2 0.37 SI
S. saprophyticus DMST 27058 128 R 8 256 16 + 2 0.37 SI
S. saprophyticus DMST 4236 128 R 8 256 16 + 2 0.37 SI
S. saprophyticus DMST 4672 128 R 8 256 16 + 2 0.37 SI
S. saprophyticus DMST 5057 128 R 8 256 16 + 2 0.37 SI
S. saprophyticus DMST 8034 128 R 8 256 16 + 2 0.37 SI
S. aureus ATCC 29213P 0.5 S 4 1 N/D N/D
S. aureus ATCC 29213 P, was used as a positive control
S Susceptible, R Resistant, SI Synergistic interaction, N/D Not determine
OXA Oxacillin, AMT α-mangostin, NIS Nisin
The MICs are presented as the median values measured from three independent experiments; each experiment was performed in triplicate
Fig. 2 HPLC chromatograms of α-mangostin: a, Alpha-mangostin (Ext.) = α-mangostin extract from G. mangostana; b, Alpha-mangostin
(Std.) = α-mangostin standard
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showed 87.5 % synergism with FIC indices between
0.0417 - 0.1333 [36].
Enzyme assays
The enzyme assay results for the isolated α-mangostin
treatment revealed that the levels of benzylpenicillin
were significantly higher compared with the controls
(p < 0.01). The levels of benzylpenicillin depended on
the isolated α-mangostin concentration in a dose-
dependent manner (p < 0.01) (Fig. 4). Previous findings
found that 82 % of Staphylococcus saprophyticus
strains produced β-lactamase [37]. Furthermore, Hir-
ano and Bayer demonstrated that in vivo efficacy of
ampicillin plus sulbactam could inhibit oxacillin-
resistant Staphylococcus aureus, which commonly pro-
duce β-lactamase [38]. In addition, previous findings
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reported that α-mangostin was found to be active
against membrane enzymes of S. mutans UA159 [39].
Furthermore, These results are in agreement with
those of Denny et al. and Zhao et al. that galangin and
epigallocatechin gallate, both sharing benzene fused
rings condensed with pyran rings (Chromone or 1,4-
benzopyrone) similar to α-mangostin, inhibited
metallo-β-lactamase and penicillinase, respectively
[40, 41]. These findings suggest that the isolated α-
mangostin from the pericarp of GML extract could be
able to inhibit β-lactamase activity. These inhibitory
results may be as a consequence of the isolated α-
mangostin form the complex with β-lactamase type IV
resulting in deactivation of the β-lactamase activity
[9]. Also, the increased of benzylpenicillin was ob-
served in a very short time interval (in minutes; Fig. 9).
This result correlates well with the rapid killing of a
membrane-targeting antimicrobial. Thus, reduction of
the β-lactamase activity could be a secondary effect
after the membrane is disrupted [42].
TEM
The transmission electron micrographs of cells from
the log phase of growth of ORSS in the presence of iso-
lated α-mangostin, oxacillin either alone and in com-
bination are presented in Fig. 5. The untreated cells
appeared normal, peptidoglycan, and cytoplasmic
membranes were clearly seen intact. And the morph-
ology of the cells looked normal (Fig. 5a). The ORSS
cells treated with oxacillin are displayed in Fig. 5b. This
result showed some disruption to both peptidoglycan
and cytoplasmic membrane. The average cross-
sectional cell areas of these cells were slightly smaller
than the controls, but there was no significant differ-
ence (p > 0.01) (Fig. 6). Although, the micrograph of
these cells after exposure to isolated α-mangostin alone
is shown in Fig. 5c. Clear damage to peptidoglycan and
the cytoplasmic membrane was evident. The average
cell areas of these cells were significantly bigger than
those of controls (p < 0.01) (Fig. 6). Fig. 5d reveals the
isolated α-mangostin plus oxacillin-treated cells. These
Fig. 5 Ultrathin sections of log phase oxacillin-resistant S. saprophyticus DMST 27055 grown in CAMHB containing: a, control (drug-free); b, oxacillin at
64 μg/ml; c, α-mangostin at 4 μg/ml; d, oxacillin at 12 μg/ml plus α-mangostin at 1.5 μg/ml; (Magnification; a, 4000×, bar = 1 μm; b, 6000×, bar = 0.5 μm;
c, 10,000×, bar = 0.5 μm; d, 10,000×, bar = 0.3 μm; Inset magnification; a, c, 38,000×; b, 29,000×; d, 10,000×; bar; a, b, c, 200 nm; d, 500 nm)
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cells displayed the greatest damage to the peptidogly-
can and cytoplasmic membrane resulting in leakage of
intracellular materials and overall morphological
changes. Clearly, these average cell areas were signifi-
cantly bigger than the control (p < 0.01) (Fig. 6). These
results provide evidence that isolated α-mangostin
shows stronger activity than oxacillin against this strain
at these concentrations. These findings agree with
previous findings where the combination of ceftazidime
plus galangin led to damage of the cell ultrastructures,
the integrity of cell walls and increase in cell size of
ceftazidime-resistant S. aureus [9]. Furthermore, this
current study shows similarity to that of the work of
Koh et al. who reported that α-mangostin caused sig-
nificant morphological effects to S. aureus (MRSA) in-
cluding wall damage and cell lysis [42].
Immunofluorescence staining and confocal microscopy
The peptidoglycan and DNA-labelled ORSS clearly
showed intact coccus-shape and no damage was
observed in untreated control cells by confocal laser
scanning images (Fig. 7). The cells treated with isolated
α-mangostin or oxacillin alone displayed minor peptido-
glycan damage and DNA leakage. The combination of
these agents caused considerable peptidoglycan damage
and DNA leakage compared to controls. The merger of
peptidoglycan and DNA images are also shown. These
results are in substantial agreement with the TEM study
and support a preliminary mechanism of action of this
combination being targeted at the peptidoglycan
structure.
CM permeabilization
The CM permeability was measured by examining the
release of UV-absorbing materials at 260 nm (Fig. 8).
After treatment, ORSS cells with isolated α-mangostin,
nisin, and the isolated α-mangostin plus oxacillin com-
bination could induce the release of 260 nm absorbing
Fig. 6 The effect of either oxacillin or α-mangostin on average
cross-section of ORSS-27055 cell areas. CON = control (drugs free);
OXA(64) = 64 μg/ml oxacillin; AMT(4) = 4 μg/ml α-mangostin;
OXA(12) + AMT(1.5) = 12 μg/ml oxacillin plus 1.5 μg/ml α-mangostin.
The mean ± SEM for three replicates are illustrated. Means sharing
the same superscript are not significantly different from each other
(Scheffe’s test, p < 0.01)
Fig. 7 Schematic representation of the results of immunofluorescence and a confocal laser scanning microscope; Samples of oxacillin-resistant
S. saprophyticus DMST 27055 after treatment for 4 h with oxacillin, α-mangostin either alone or in combination. CON = control (drugs free); OXA(64) =
64 μg/ml oxacillin; AMT(4) = 4 μg/ml α-mangostin; OXA(12) + AMT(1.5) = 12 μg/ml oxacillin plus 1.5 μg/ml α-mangostin. The cells were stained for DNA
with DAPI (blue, DNA) and labelled for peptidoglycan (green, PGC) using respective antibodies. DNA in all groups was localized in the central of the cell
and surrounded by a peptidoglycan layer (MERGED). Scale bar = 1 μm
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Fig. 8 Effects of 260 nm absorbing material (DNA, RNA, and metabolites) in the ORSS-27055 supernatants. These cells were treated with oxacillin,
α-mangostin either alone or in combination. CON = control (drugs free); OXA(64) = 64 μg/ml oxacillin; AMT(4) = 4 μg/ml α-mangostin; OXA(12) +
AMT(1.5) = 12 μg/ml oxacillin plus 1.5 μg/ml α-mangostin; NIS(0.5) = 0.50 μg/ml nisin. Nisin at 0.50 μg/ml was used as a positive control, and
untreated cells were used as a negative control. The mean ± SEM for three replicates are illustrated. Means sharing the same superscript at the
same time are not significantly different (Scheffe’s test, p < 0.01)
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Fig. 9 Time-dependency of oxacillin plus α-mangostin-induced permeabilisation of the cytoplasmic membrane of ORSS-27055. The kinetics of
α-mangostin-mediated ONPG passage across the cytoplasmic membrane are monitored as a change in the optical density (OD). The concentration of
substrates was 100 μg/ml ONPG. CON= control (drugs free); OXA(64) = 64 μg/ml oxacillin; AMT(4) = 4 μg/ml α-mangostin; OXA(12) + AMT(1.5) = 12 μg/ml
oxacillin plus 1.5 μg/ml α-mangostin; NIS(0.5) = 0.50 μg/ml nisin. Nisin at 0.50 μg/ml was used as a positive control, and untreated cells were used as a
negative control. Each treatment performed two times in triplicate. The graph shows OD420nm of each treatment at the same time. Means sharing the
same superscript at the same time are not significantly different from each other (Scheffe’s test, p< 0.01)
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materials at significantly higher levels compared with
the control or oxacillin alone (p < 0.01). The CM permeabi-
lising ability was ranked as follows isolated α-mangostin
plus oxacillin > nisin > isolated α-mangostin > oxacillin >
control (p < 0.01). These results suggested that the synergis-
tic activity of isolated α-mangostin plus oxacillin resulted in
increased cytoplasmic membrane permeability of DNA,
RNA, and cellular metabolites [26, 27].
The α-mangostin-induced CM permeabilisation of
the ORSS by ONPG uptake results are shown in Fig. 9.
The ORSS cytoplasmic membrane was permeabilised
much more rapidly by the isolated α-mangostin plus
oxacillin compared to other groups. Nisin, which is
highly active against the outer membrane, showed CM
permeability significantly lower than isolated α-
mangostin and oxacillin combination (p < 0.01). These
Fig. 10 The effect of oxacillin, α-mangostin either alone or in combination on 3T3-L1 preadipocytes. 3T3-L1 preadipocytes were treated with:
a. oxacillin (0-2048 μg/ml); b. α-mangostin (0-128 μg/ml); and c. oxacillin plus α-mangostin (8 + 1 to 512 + 64 μg/ml), for 24 h. Results are
expressed as percentages of cell viability as compared with untreated controls (n = 8). The mean ± SEM for three replicates are illustrated. Means
sharing the same superscript are not significantly different from each other (Scheffe’s test, p < 0.01)
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results are consistent with the results of CM perme-
abilisation with the UV-absorbing material at 260 nm
(Fig. 8). In the same way, previous studies found that
galangin, which shares the chromone (or 1,4-benzopyrone)
structure with α-mangostin, caused CM permeabilisation of
S. aureus resulting in potassium loss [9, 43].
Our findings lend support to previous findings that
α‐mangostin rapidly disrupted the integrity of the
cytoplasmic membrane of MRSA cells, leading to los-
ing of intracellular components in a concentration-
dependent manner [42]. The CM permeability results
provide evidence that one of the important mechan-
ism of action of isolated α-mangostin is disruption of
the cytoplasmic membrane. This disruption in turn
leads to deactivation of the β-lactamase activity.
Plant-derived antibacterial compounds have weaker
antibacterial activity compared to that of synthetic anti-
biotics. Therefore, synergistic paradigms by combining
the conventional antibiotic with phytochemical com-
pounds is proven in several studies to be an effective
avenue to treat infectious diseases caused by drug-
resistant bacteria [7–9]. Synergistic interaction combats
drug-resistant bacteria by achieving multiple synergistic
drug targets, interacting with drug-resistant mecha-
nisms of bacteria, and neutralising and eliminating ad-
verse effects [7].
Previous studies found that ceftazidime had synergis-
tic activity with baicalein, luteolin or quercetin, which
shared Chromone structure, against Streptococcus pyo-
genase [23, 44]. In the same way, Eumkeb and co-
workers reported that certain β-lactam drugs plus
galangin, quercetin or baicalein, which also shared
chromone structure, showed synergistic activity against
penicillin-resistant S. aureus [9]. Besides, Rukayadi
et al. found that Panduratin A, which possesses a ben-
zene ring and an isoprenyl group, displayed an MIC of
1 μg/ml for staphylococcal clinical isolates and generally
was more potent than commonly used antimicrobials [45].
Also, molecular dynamic simulations revealed that isopre-
nyl groups of α-mangostin, which occupy chromone struc-
ture and isoprenyl groups, played an important role in
penetrating the lipid bilayer of the MRSA membrane result-
ing in membrane breakdown and increased permeability
[42]. These findings provide evidence that the benzene ring
and the isoprenyl group of both panduratin A and α-
mangostin play a significant role in inhibiting the growth of
MRSA strains by s direct interactions with the bacterial
membrane [42, 45].
In vitro cytotoxic test (MTT assays)
The results of the MTT assays are shown in Fig. 10. The
α-mangostin or oxacillin alone initially exhibited cyto-
toxicity against 3T3-L1 preadipocytes at concentrations
128 and 1024 μg/ml, respectively, which is 16 and 8
times higher than the MICs of α-mangostin and oxacil-
lin against S. saprophyticus respectively (Fig. 10a and b).
Moreover, Fig. 10c revealed the combination of α-
mangostin and oxacillin at concentrations of 2 and
16 μg/ml, which showed the synergistic effect of antibacter-
ial activity against this strain, had no cytotoxic effect to-
wards 3T3-L1 preadipocytes after 24 h of exposure.
Moreover, the four times higher than FICI value, 64 μg/ml
oxacillin plus 8 μg/ml α-mangostin, still did not show the
cytotoxic effect on 3T3-L1 preadipocytes. Our findings pro-
vide evidence that the MICs and higher dosages of agents
have not shown a cytotoxic effect on this cell line. Import-
antly, a greatly desired property of antibacterial compounds
is the selective inhibition against bacterial with less cyto-
toxic effect to normal cells for avoiding side effects to
healthy tissues [46]. The previous studies reported that the
IC50 of α-mangostin on the MRC-5 cell line is at the con-
centration of 7.5 μM [47] and 50 μM on 3T3-L1 preadipo-
cyte cell line [48]. These findings imply that α-mangostin
used alone or in combination may be useful in developing a
novel adjunct phytopharmaceutical to oxacillin for the
treatment of ORSS.
Conclusions
In conclusion, our findings provide evidence that iso-
lated α-mangostin from the pericarp of GML alone has
not only some activity against ORSS but also possesses
the synergistic activity with oxacillin against this strain.
The chromone (or 1,4-benzopyrone) structure and iso-
prenyl groups of α-mangostin could play an important
role in inhibiting this strain. This synergistic activity of
isolated α-mangostin plus oxacillin may involve three
modes of action of this xanthone. Firstly, potential ef-
fects of cytoplasmic membrane disruption and increases
permeability. Secondly, inhibition of β-lactamase activity.
Finally, peptidoglycan damage. Our findings provide evi-
dence that isolated α-mangostin from the pericarp of
GML has a sufficient margin of safety for therapeutic
use. Isolated α-mangostin provides potential to develop
a useful of novel adjunct phytopharmaceutical to oxacil-
lin for the treatment of ORSS. Future studies should ad-
dress toxicity tests in animals and humans.
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